| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Thursday, January 19, 2023 3:08:31 PM
I won’t spend much time arguing on this point KF. Conceded.
However as to lack of interest and patents on DC technology, that is not true. I know of multiple under the radar efforts right now that have been going on for years at top research institutions utilizing very similar technology and actually getting encouraging results. Additionally in my own research on the patents I discovered that a good friend who is a top cancer researcher, who knows Dr. Liau well from medical training years has a DC patent.
People continue to rack up patents on obscure and useful topics all the time. There are lots of research areas and DC cells are a well researched and critical area of immune therapy research. By far NWBO is not the only interested party. But I will say that much of the research is happening at via research hospitals and universities still and is therefore mostly off the radar of investors.
However as to lack of interest and patents on DC technology, that is not true. I know of multiple under the radar efforts right now that have been going on for years at top research institutions utilizing very similar technology and actually getting encouraging results. Additionally in my own research on the patents I discovered that a good friend who is a top cancer researcher, who knows Dr. Liau well from medical training years has a DC patent.
People continue to rack up patents on obscure and useful topics all the time. There are lots of research areas and DC cells are a well researched and critical area of immune therapy research. By far NWBO is not the only interested party. But I will say that much of the research is happening at via research hospitals and universities still and is therefore mostly off the radar of investors.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
